BNP Paribas Financial Markets reduced its position in Hamilton Lane Incorporated (NASDAQ:HLNE - Free Report) by 50.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,750 shares of the company's stock after selling 20,300 shares during the period. BNP Paribas Financial Markets' holdings in Hamilton Lane were worth $2,924,000 as of its most recent SEC filing.
Several other hedge funds have also recently bought and sold shares of the company. AXA S.A. purchased a new position in Hamilton Lane in the 4th quarter valued at approximately $459,000. Caisse DE Depot ET Placement DU Quebec purchased a new position in Hamilton Lane in the 4th quarter valued at approximately $1,229,000. Kapitalo Investimentos Ltda purchased a new position in Hamilton Lane in the 4th quarter valued at approximately $65,000. Northern Trust Corp increased its stake in Hamilton Lane by 3.2% in the 4th quarter. Northern Trust Corp now owns 623,735 shares of the company's stock valued at $92,344,000 after purchasing an additional 19,514 shares in the last quarter. Finally, Tudor Investment Corp ET AL purchased a new position in Hamilton Lane in the 4th quarter valued at approximately $677,000. 97.40% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
HLNE has been the subject of several research analyst reports. Oppenheimer downgraded Hamilton Lane from an "outperform" rating to a "market perform" rating in a research note on Thursday. Keefe, Bruyette & Woods raised their price target on Hamilton Lane from $158.00 to $168.00 and gave the stock a "market perform" rating in a research report on Wednesday, February 5th. Wells Fargo & Company dropped their price target on Hamilton Lane from $152.00 to $147.00 and set an "equal weight" rating for the company in a research report on Tuesday, April 8th. Morgan Stanley dropped their price target on Hamilton Lane from $190.00 to $157.00 and set an "equal weight" rating for the company in a research report on Monday, April 14th. Finally, JPMorgan Chase & Co. dropped their price target on Hamilton Lane from $176.00 to $167.00 and set a "neutral" rating for the company in a research report on Tuesday, April 29th. One equities research analyst has rated the stock with a sell rating and six have assigned a hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $164.14.
View Our Latest Research Report on HLNE
Hamilton Lane Price Performance
Shares of NASDAQ:HLNE opened at $170.11 on Friday. The company has a market cap of $9.43 billion, a P/E ratio of 31.39 and a beta of 1.31. The company has a quick ratio of 4.19, a current ratio of 4.19 and a debt-to-equity ratio of 0.34. Hamilton Lane Incorporated has a 52 week low of $114.85 and a 52 week high of $203.72. The business has a fifty day simple moving average of $148.58 and a 200-day simple moving average of $159.96.
Hamilton Lane Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 4th. Stockholders of record on Friday, March 14th were given a $0.49 dividend. This represents a $1.96 dividend on an annualized basis and a dividend yield of 1.15%. The ex-dividend date of this dividend was Friday, March 14th. Hamilton Lane's dividend payout ratio is currently 36.16%.
About Hamilton Lane
(
Free Report)
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
See Also
Want to see what other hedge funds are holding HLNE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hamilton Lane Incorporated (NASDAQ:HLNE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hamilton Lane, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.
While Hamilton Lane currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.